Influence of clonidine and ketamine on m-RNA expression in a model of opioid-induced hyperalgesia in mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Ohnesorge, Henning ^a   Feng, Zhiying ^b   Zitta, Karina ^a   Steinfath, Markus ^a   Albrecht, Martin ^a   Bein, Berthold ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 2; CLONIDINE; ESKETAMINE; KETAMINE; MESSENGER RNA; MORPHINE; MORPHINSULFAT GRY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; OPIATE; PROTEIN C FOS; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG DOSE INCREASE; GENE EXPRESSION REGULATION; HYPERALGESIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN THRESHOLD; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; ARRESTINS; BRAIN; CLONIDINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERALGESIA; KETAMINE; MALE; MICE; MICE, INBRED C57BL; MORPHINE; PAIN; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 84891405428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079567     Document Type: Article

References (45)

1. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT et al. (2009) Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 18: 1166-1175. doi:10.1002/pds.1833. PubMed: 19718704.
2. Angst MS, Clark JD (2006) Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104: 570-587. doi:10.1097/00000542-200603000- 00025. PubMed: 16508405.
3. Chu LF, Angst MS, Clark DMDP (2008) Opioid-induced Hyperalgesia in Humans: Molecular Mechanisms and Clinical Considerations. Clin J Pain 24: 479-496. doi:10.1097/AJP.0b013e31816b2f43. PubMed: 18574358.
4. Joly V, Richebe P, Guignard B, Fletcher D, Maurette P et al. (2005) Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103: 147-155. doi:10.1097/00000542- 200507000-00022. PubMed: 15983467.
5. Chu LF, Clark DJ, Angst MS (2006) Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 7: 43-48. doi:10.1016/j.jpain.2005.08.001. PubMed: 16414554.
6. Chen L, Malarick C, Seefeld L, Wang S, Houghton M et al. (2009) Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain 143: 65-70. doi:10.1016/j.pain.2009.01.022. PubMed: 19237249.
7. Mao J (2002) Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 100: 213-217. doi:10.1016/S0304-3959(02)00422-0. PubMed: 12467992.
8. Rome JD, Townsend CO, Bruce BK, Sletten CD, Luedtke CA et al. (2004) Chronic noncancer pain rehabilitation with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Mayo Clin Proc 79: 759-768. doi:10.1016/S0025-6196(11)62628-1. PubMed: 15182090.
9. Laulin JP, Larcher A, Célèrier E, Le Moal M, Simonnet G (1998) Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur J Neurosci 10: 782-785. PubMed: 9749743.
10. Solomon RL, Corbit JD (1974) An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev 81: 119-145. doi:10.1037/h0036128. PubMed: 4817611.
11. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M (2003) Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 106: 49-57. doi:10.1016/S0304-3959(03)00276-8. PubMed: 14581110.
12. Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M et al. (2003) Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 99: 152-159. doi:10.1097/00000542-200307000-00025. PubMed: 12826855.
13. Gowing LR, Farrell M, Ali RL, White JM (2002) Alpha2-adrenergic agonists in opioid withdrawal. Addiction 97: 49-58. doi:10.1046/j.1360-0443.2002.00037.x. PubMed: 11895270.
14. Koch T, Höllt V (2008) Role of receptor internalization in opioid tolerance and dependence. Pharmacol Therapeutics 117: 199-206. doi:10.1016/j.pharmthera.2007.10.003. PubMed: 18076994.
15. Sandkühler J (2009) Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 89: 707-758. doi:10.1152/physrev.00025.2008. PubMed: 19342617.
16. Le Bars D, Gozariu M, Cadden SW (2001) Animal models of nociception. Pharmacol Rev 53: 597-652. PubMed: 11734620.
17. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63. doi:10.1016/0165-0270(94)90144-9. PubMed: 7990513.
18. Lichtman AH, Smith FL, Martin BR (1993) Evidence that the antinociceptive tail-flick response is produced independently from changes in either tail-skin temperature or core temperature. Pain 55: 283-295. doi:10.1016/0304-3959(93) 90003-8. PubMed: 8121689.
19. Osikowicz M, Mika J, Makuch W, Przewlocka B (2008) Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. Pain 139: 117-126. doi:10.1016/j.pain.2008. 03.017. PubMed: 18442882.
20. Starowicz K, Bilecki W, Sieja A, Przewlocka B, Przewlocki R (2004) Melanocortin 4 receptor is expressed in the dorsal root ganglions and down-regulated in neuropathic rats. Neurosci Lett 358: 79-82. doi:10.1016/j.neulet.2003.12.096. PubMed: 15026153.
21. Mao J, Price DD, Mayer DJ (1994) Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 14: 2301-2312. PubMed: 7908958.
22. Juni A, Klein G, Kest B (2006) Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res 1070: 35-44. doi:10.1016/j.brainres.2005.11.054. PubMed: 16409995.
23. Célèrier E, Rivat C, Jun Y, Laulin JP, Larcher A et al. (2000) Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92: 465-472. doi:10.1097/00000542-200002000-00029. PubMed: 10691234.
24. Rivat C, Laulin JP, Corcuff JB, Célèrier E, Pain L et al. (2002) Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology 96: 381-391. doi:10.1097/00000542-200202000-00025. PubMed: 11818772.
25. Waxman AR, Arout C, Caldwell M, Dahan A, Kest B (2009) Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice. Neurosci Lett 462: 68-72. doi:10.1016/j.neulet.2009.06.061. PubMed: 19559072.
26. Célérier E, González JR, Maldonado R, Cabañero D, Puig MM (2006) Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase. Anesthesiology 104: 546-555. doi:10.1097/00000542-200603000- 00023. PubMed: 16508403.
27. Li X, Eisenach JC (2001) alpha2A-adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes. J Pharmacol Exp Ther 299: 939-944. PubMed: 11714880.
28. De Kock M, Lavand'homme P, Waterloos H (2005) The short-lasting analgesia and long-term antihyperalgesic effect of intrathecal clonidine in patients undergoing colonic surgery. Anesth Analg 101: 566-572, table of contents doi:10.1213/01.ANE.0000157121.71808.04. PubMed: 16037177.
29. Fairbanks CA, Wilcox GL (1999) Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. J Pharmacol Exp Ther 288: 1107-1116. PubMed: 10027848.
30. Li X, Angst MS, Clark JD (2001) A murine model of opioid-induced hyperalgesia. Mol Brain Res 86: 56-62. doi:10.1016/S0169-328X(00)00260-6. PubMed: 11165371.
31. Himmelseher S, Durieux ME (2005) Ketamine for perioperative pain management. Anesthesiology 102: 211-220. doi:10.1097/00000542-200501000-00030. PubMed: 15618805.
32. Koppert W, Schmelz M (2007) The impact of opioid-induced hyperalgesia for postoperative pain. Best Pract Res Clin Anaesthesiol 21: 65-83. doi:10.1016/j.bpa.2006.12.004. PubMed: 17489220.
33. Chu LF, Angst MS, Clark D (2008) Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 24: 479-496. doi:10.1097/AJP.0b013e31816b2f43. PubMed: 18574358.
34. Crain SM, Shen KF (2000) Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 84: 121-131. doi:10.1016/S0304-3959(99) 00223-7. PubMed: 10666516.
35. Li X, Angst MS, Clark JD (2001) A murine model of opioid-induced hyperalgesia. Brain Res. Mol Brain Res 86: 56-62. doi:10.1016/S0169-328X(00) 00260-6. PubMed: 11165371.
36. Mao J, Sung B, Ji RR, Lim G (2002) Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 22: 8312-8323. PubMed: 12223586.
37. Li X, Angst MS, Clark JD (2001) Opioid-induced hyperalgesia and incisional pain. Anesth Analg 93: 204-209. PubMed: 11429366.
38. Célèrier E, Laulin J, Larcher A, Le Moal M, Simonnet G (1999) Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res 847: 18-25. doi:10.1016/S0006-8993(99)01998-8. PubMed: 10564731.
39. DuPen A, Shen D, Ersek M (2007) Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag Nurs 8: 113-121. doi:10.1016/j.pmn.2007.02.004. PubMed: 17723928.
40. Bohn LM, Lefkowitz RJ, Caron MG (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knockout mice. J Neurosci 22: 10494-10500. PubMed: 12451149.
41. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG et al. (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286: 2495-2498. doi:10.1126/science.286.5449.2495. PubMed: 10617462.
42. Appleyard SM, Celver J, Pineda V, Kovoor A, Wayman GA et al. (1999) Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin. J Biol Chem 274: 23802-23807. doi:10.1074/jbc.274.34.23802. PubMed: 10446141.
43. Jiang B, Shi Y, Li H, Kang L, Ma L (2006) Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray. Neurosci Lett 400: 150-153. doi:10.1016/j.neulet.2006.02.071. PubMed: 16563622.
44. Hong D, Flood P, Diaz G (2008) The side effects of morphine and hydromorphone patient-controlled analgesia. Anesth Analg 107: 1384-1389. doi:10.1213/ane.0b013e3181823efb. PubMed: 18806056.
45. Chang SL, Squinto SP, Harlan RE (1988) Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Commun 157: 698-704. doi:10.1016/S0006-291X(88)80306-1. PubMed: 3144275.